These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 28599435)

  • 1. Expression of regulatory factor X1 can predict the prognosis of breast cancer.
    Shibata M; Kanda M; Shimizu D; Tanaka H; Umeda S; Hayashi M; Inaishi T; Miyajima N; Adachi Y; Takano Y; Nakanishi K; Takeuchi D; Noda S; Kodera Y; Kikumori T
    Oncol Lett; 2017 Jun; 13(6):4334-4340. PubMed ID: 28599435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory factor X1 is a new tumor suppressive transcription factor that acts via direct downregulation of CD44 in glioblastoma.
    Feng C; Zhang Y; Yin J; Li J; Abounader R; Zuo Z
    Neuro Oncol; 2014 Aug; 16(8):1078-85. PubMed ID: 24526308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory Factor X1 Downregulation Contributes to Monocyte Chemoattractant Protein-1 Overexpression in CD14+ Monocytes
    Jia S; Yang S; Du P; Gao K; Cao Y; Yao B; Guo R; Zhao M
    Front Genet; 2019; 10():1098. PubMed ID: 31737059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of RFX1 predicts poor prognosis of patients with small hepatocellular carcinoma.
    Liu Y; Jiang P; Wang G; Liu X; Luo S
    Eur J Surg Oncol; 2018 Jul; 44(7):1087-1093. PubMed ID: 29764705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RFX1 downregulation contributes to TLR4 overexpression in CD14
    Du P; Gao K; Cao Y; Yang S; Wang Y; Guo R; Zhao M; Jia S
    Clin Epigenetics; 2019 Mar; 11(1):44. PubMed ID: 30857550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of an epigenetically silenced gene, RFX1, in human glioma cells using restriction landmark genomic scanning.
    Ohashi Y; Ueda M; Kawase T; Kawakami Y; Toda M
    Oncogene; 2004 Oct; 23(47):7772-9. PubMed ID: 15334059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MZB1 expression indicates poor prognosis in estrogen receptor-positive breast cancer.
    Watanabe M; Shibata M; Inaishi T; Ichikawa T; Soeda I; Miyajima N; Takano Y; Takeuchi D; Tsunoda N; Kanda M; Kikumori T; Kodera Y; Nagino M
    Oncol Lett; 2020 Nov; 20(5):198. PubMed ID: 32963604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockout of the regulatory factor X1 gene leads to early embryonic lethality.
    Feng C; Xu W; Zuo Z
    Biochem Biophys Res Commun; 2009 Sep; 386(4):715-7. PubMed ID: 19559676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the transcription factor regulatory factor X1 in the mouse brain.
    Feng C; Li J; Zuo Z
    Folia Histochem Cytobiol; 2011; 49(2):344-51. PubMed ID: 21744337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of regulatory factor X1 binding sites in promoters of RNA-binding proteins genes in mouse brain.
    Liu XJ; Zhao ZH; Liu XM
    Arch Iran Med; 2013 Jul; 16(7):390-6. PubMed ID: 23808775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NEDD4 expression is associated with breast cancer progression and is predictive of a poor prognosis.
    Wan L; Liu T; Hong Z; Pan Y; Sizemore ST; Zhang J; Ma Z
    Breast Cancer Res; 2019 Dec; 21(1):148. PubMed ID: 31856858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetics and SLE: RFX1 downregulation causes CD11a and CD70 overexpression by altering epigenetic modifications in lupus CD4+ T cells.
    Zhao M; Sun Y; Gao F; Wu X; Tang J; Yin H; Luo Y; Richardson B; Lu Q
    J Autoimmun; 2010 Aug; 35(1):58-69. PubMed ID: 20223637
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Shibata M; Kanda M; Shimizu D; Tanaka H; Umeda S; Miwa T; Hayashi M; Inaishi T; Miyajima N; Adachi Y; Takano Y; Nakanishi K; Takeuchi D; Noda S; Kodera Y; Kikumori T
    Oncol Lett; 2018 Dec; 16(6):7223-7230. PubMed ID: 30546460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autorepression of rfx1 gene expression: functional conservation from yeast to humans in response to DNA replication arrest.
    Lubelsky Y; Reuven N; Shaul Y
    Mol Cell Biol; 2005 Dec; 25(23):10665-73. PubMed ID: 16287876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The genes for MHC class II regulatory factors RFX1 and RFX2 are located on the short arm of chromosome 19.
    Pugliatti L; Derré J; Berger R; Ucla C; Reith W; Mach B
    Genomics; 1992 Aug; 13(4):1307-10. PubMed ID: 1505960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of transcription factors RFX1 and MIBP1 with the gamma motif of the negative regulatory element of the hepatitis B virus core promoter.
    Buckwold VE; Chen M; Ou JH
    Virology; 1997 Jan; 227(2):515-8. PubMed ID: 9018153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of Myc-intron-binding polypeptides MIBP1 and RFX1 during retinoic acid-mediated differentiation of haemopoietic cells.
    Zajac-Kaye M; Ben-Baruch N; Kastanos E; Kaye FJ; Allegra C
    Biochem J; 2000 Feb; 345 Pt 3(Pt 3):535-41. PubMed ID: 10642512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in clinical importance of Bcl-2 in breast cancer according to hormone receptors status or adjuvant endocrine therapy.
    Honma N; Horii R; Ito Y; Saji S; Younes M; Iwase T; Akiyama F
    BMC Cancer; 2015 Oct; 15():698. PubMed ID: 26472348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcription factor RFX1 helps control the promoter of the mouse ribosomal protein-encoding gene rpL30 by binding to its alpha element.
    Sáfrány G; Perry RP
    Gene; 1993 Oct; 132(2):279-83. PubMed ID: 8224874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RFX1: a promising therapeutic arsenal against cancer.
    Issac J; Raveendran PS; Das AV
    Cancer Cell Int; 2021 May; 21(1):253. PubMed ID: 33964962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.